Phosphodiesterase 5 Inhibition Improves β-Cell Function in Metabolic Syndrome

OBJECTIVE: This study tested the hypothesis that phosphodiesterase 5 inhibition alone or in combination with ACE inhibition improves glucose homeostasis and fibrinolysis in individuals with metabolic syndrome. RESEARCH DESIGN AND METHODS: Insulin sensitivity, β-cell function, and fibrinolytic parame...

Descripción completa

Detalles Bibliográficos
Autores principales: Hill, Kevin D., Eckhauser, Aaron W., Marney, Annis, Brown, Nancy J.
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2009
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2671107/
https://www.ncbi.nlm.nih.gov/pubmed/19196886
http://dx.doi.org/10.2337/dc08-1862

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2671107/
https://www.ncbi.nlm.nih.gov/pubmed/19196886
http://dx.doi.org/10.2337/dc08-1862

Ejemplares similares